Sikorska H M
J Immunol. 1986 Dec 15;137(12):3786-95.
The objective of this study was to find naturally occurring anti-idiotypic (anti-Id) antibodies to anti-human thyroglobulin (anti-hTg) idiotype in sera of patients with autoimmune thyroid disease. Sera from patients with Hashimoto's thyroiditis (HT), Graves' disease (GD), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) and sera from normal subjects were tested for the presence of anti-Id antibodies against mouse anti-hTg monoclonal antibodies (McAb) in indirect ELISA and in indirect solid-phase RIA. Microtitration plates were coated with six McAb, five of them directed against different epitopes on hTg molecule, and then incubated with patients' sera. The bound antibody was detected with either peroxidase or 125I-labeled anti-human IgG. The specific positive reaction was observed in four of 40 patients with HT, in two of 26 patients with GD, in seven of 58 patients with RA, and in none of 20 normal subjects. The detected binding was due to the presence of anti-hTg anti-Id antibodies and not to Tg-anti-Tg circulating immune complexes, as the positive sera did not contain hTg when resolved on SDS-PAGE, nor did they bind to all anti-hTg McAb tested. The binding was dose dependent, and titers of anti-Id antibodies varied from 1:243 to 1:2187. The binding could be inhibited up to 50% by hTg, but not by the thyroid microsomal antigen, indicating that some of those anti-Id might represent the internal image of the antigen. Serum from the patient 3403, showing the strongest reactivity against McAb A-3, was chosen for IgG purification and F(ab')2 fragment isolation. The 3403 F(ab')2 fragment, but not the Fc fragment, was found to react specifically with four mouse anti-hTg McAb but not with the control mouse IgG. Thus, the obtained results permit the conclusion that anti-hTg anti-Id antibodies could occur naturally during the course of thyroid autoimmune disorders.
本研究的目的是在自身免疫性甲状腺疾病患者的血清中寻找针对抗人甲状腺球蛋白(抗-hTg)独特型的天然存在的抗独特型(抗-Id)抗体。采用间接酶联免疫吸附测定(ELISA)和间接固相放射免疫测定(RIA)检测桥本甲状腺炎(HT)、格雷夫斯病(GD)、类风湿关节炎(RA)和系统性红斑狼疮(SLE)患者以及正常受试者血清中针对小鼠抗-hTg单克隆抗体(McAb)的抗-Id抗体的存在情况。微量滴定板用六种McAb包被,其中五种针对hTg分子上的不同表位,然后与患者血清孵育。用辣根过氧化物酶或125I标记的抗人IgG检测结合的抗体。在40例HT患者中有4例、26例GD患者中有2例、58例RA患者中有7例观察到特异性阳性反应,而20例正常受试者中无一例出现阳性反应。检测到的结合是由于存在抗-hTg抗-Id抗体,而非Tg-抗-Tg循环免疫复合物,因为阳性血清在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)上分离时不含hTg,也不与所有检测的抗-hTg McAb结合。这种结合呈剂量依赖性,抗-Id抗体的效价从1:243到1:2187不等。hTg可使这种结合抑制达50%,但甲状腺微粒体抗原不能,这表明其中一些抗-Id可能代表抗原的内影像。选择对McAb A-3反应最强的患者3403的血清进行IgG纯化和F(ab')2片段分离。发现3403 F(ab')2片段而非Fc片段能与四种小鼠抗-hTg McAb特异性反应,但不与对照小鼠IgG反应。因此,所得结果可以得出结论,抗-hTg抗-Id抗体可在甲状腺自身免疫性疾病过程中自然出现。